Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Oral Arsenic Trioxide Based Regimen As Salvage Treatment For Relapsed Or Refractory Mantle Cell Lymphoma

Harinder Gill, MBBS, MRCP (UK), Wing-Yan Au, MD, Winnie W.W. Cheung, MBBS, MRCP, FHKCP, FHKAM, Yok Lam Kwong, MD

Blood (2013) 122 (21): 4346.

https://doi.org/10.1182/blood.V122.21.4346.4346

Published: 2013

Journal Articles

Oral Arsenic Trioxide - Based Maintenance Without Hematopoietic Stem Cell Transplantation At Second Remission In Acute Promyelocytic Leukemia - A Prospective Follow-Up Study Of 65 Patients

Harinder Gill, MBBS, MRCP (UK), Wing-Yan Au, MD, Yok Lam Kwong, MD

Blood (2013) 122 (21): 2678.

https://doi.org/10.1182/blood.V122.21.2678.2678

Published: 2013

Journal Articles

Rituximab Maintenance Significantly Prolongs Event Free (EFS) and Progression Free Survival (PFS) In Male Patients With Aggressive B-Cell Lymphoma In The NHL13 Study

Blood (2013) 122 (21): 851.

https://doi.org/10.1182/blood.V122.21.851.851

Published: 2013

Journal Articles

A Population Based Study of 408 Cases of Acute Promyelocytic Leukemia Showing Changes in Epidemiology and Prognosis During Two Decades: Impact of Oral Arsenic Trioxide,

Wing-Yan Au, MD, Dennis Ip, MD, Oscar Mang, PhD, Kit Fai Wong, MD, Margaret Ng, MD, Thomas SK Wan, PhD, Eudora Chow, MD, Michael LG Wong, MD, Chi Kuen Lau, MD, Bhonnie Kho, MD, Ching Wa Lau, MD, Edmond SK Ma, MD, Cyrus Kumana, MD, Yok Lam Kwong, MD

Blood (2011) 118 (21): 3597.

https://doi.org/10.1182/blood.V118.21.3597.3597

Published: 2011

Journal Articles

Epigenetic Silencing of the Receptor Tyrosine Phosphatase, PTPRK , Located At the Frequently Deleted 6q22.33-q23.2 Region, Leads to Tumor Growth Via the Constitutive Activation of STAT3 in Nasal-Type NK/T-Cell Lymphoma

Yun-Wen Chen, Tianhuan Guo, Lijun Shen, Kai-Yau Wong, Wing-Yan Au, MD, Qian Tao, Lok-Yi Wong, Cheuk-On Tang, Wai Lap Choi, Wei-Ping Liu, Gan-Di Li, Norio Shimizu, Junjiro Tsuchiyama, Florence Loong, Raymond Liang, MD, FRCP, Yok Lam Kwong, MD, Gopesh Srivastava, Ph.D

Blood (2011) 118 (21): 1378.

https://doi.org/10.1182/blood.V118.21.1378.1378

Published: 2011

Journal Articles

Molecular Signatures to Improve Diagnosis, Prognostication and Identification of Oncogenic Pathways in Peripheral T and NK Cell Lymphoma.

Javeed Iqbal, Ph.D., Dennis Weisenburger, MD, Timothy C. Greiner, MS, MD, Shigeo Nakamura, MD, Julie M. Vose, MD, Masao Seto, MD, PhD, Jan Delabie, MD, Francoise Berger, Florence Loong, MD, Wing-Yan Au, MD, Young-Hyeh Ko, MD, Ivy Sng, MD, Lynette M Smith, MS, Can Kucuk, BS, Huimin Geng, MS, James Armitage, MD, Wing C. Chan, MD

Blood (2008) 112 (11): 3339.

https://doi.org/10.1182/blood.V112.11.3339.3339

Published: 2008

Journal Articles

Treatment of Relapsed Acute Promyelocytic Leukemia with Oral Arsenic Trioxide: An Eleven-Year Experience

Wing-Yan Au, MD, Sidney Tam, MD, Anskar Y.H. Leung, MD, Eric Tse, MD, Cyrus Kumana, MD, Yok Lam Kwong, MD

Blood (2008) 112 (11): 2958.

https://doi.org/10.1182/blood.V112.11.2958.2958

Published: 2008

Journal Articles

Oral Arsenic Trioxide without Chemotherapy as Maintenance Therapy for Patients with Acute Promyelocytic Leukemia in First Complete Remssion

Wing-Yan Au, MD, Sidney Tam, MD, Anskar Y.H. Leung, MD, Eric Tse, MD, Cyrus Kumana, MD, Yok Lam Kwong, MD

Blood (2008) 112 (11): 2959.

https://doi.org/10.1182/blood.V112.11.2959.2959

Published: 2008

Journal Articles

A Novel beta-delta Globin Gene Fusion Leads to Over-Expression of Delta Globin Chain and a Mild Thalassemia Intermedia Phenotype When Co-Inherited with β 0 -Thalassemia.

Chi-Chiu So, BSc, MBBS, Amy Y.Y. Chan, MPhil, Stella T.Y. Tsang, BSc, Anselm C.W. Lee, MBBS, Wing-Yan Au, MD, Edmond ShiuKwan, Ma MD, Li-Chong Chan, MA,MBBChir,PhD

Blood (2006) 108 (11): 1587.

https://doi.org/10.1182/blood.V108.11.1587.1587

Published: 2006

Journal Articles

Arsenic Trioxide in Mantle Cell Lymphoma.

Yok Lam Kwong, MD, Chit Chow, MPhil, Cyrus R. Kumana, MD, Gopesh Srivastava, PhD, Wing Yan Au, MD

Blood (2005) 106 (11): 4814.

https://doi.org/10.1182/blood.V106.11.4814.4814

Published: 2005

NARROW

Oral Arsenic Trioxide Based Regimen As Salvage Treatment For Relapsed Or Refractory Mantle Cell Lymphoma

Oral Arsenic Trioxide - Based Maintenance Without Hematopoietic Stem Cell Transplantation At Second Remission In Acute Promyelocytic Leukemia - A Prospective Follow-Up Study Of 65 Patients

Rituximab Maintenance Significantly Prolongs Event Free (EFS) and Progression Free Survival (PFS) In Male Patients With Aggressive B-Cell Lymphoma In The NHL13 Study

A Population Based Study of 408 Cases of Acute Promyelocytic Leukemia Showing Changes in Epidemiology and Prognosis During Two Decades: Impact of Oral Arsenic Trioxide,

Epigenetic Silencing of the Receptor Tyrosine Phosphatase, PTPRK , Located At the Frequently Deleted 6q22.33-q23.2 Region, Leads to Tumor Growth Via the Constitutive Activation of STAT3 in Nasal-Type NK/T-Cell Lymphoma

Molecular Signatures to Improve Diagnosis, Prognostication and Identification of Oncogenic Pathways in Peripheral T and NK Cell Lymphoma.

Treatment of Relapsed Acute Promyelocytic Leukemia with Oral Arsenic Trioxide: An Eleven-Year Experience

Oral Arsenic Trioxide without Chemotherapy as Maintenance Therapy for Patients with Acute Promyelocytic Leukemia in First Complete Remssion

A Novel beta-delta Globin Gene Fusion Leads to Over-Expression of Delta Globin Chain and a Mild Thalassemia Intermedia Phenotype When Co-Inherited with β 0 -Thalassemia.

Arsenic Trioxide in Mantle Cell Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only